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ABSTRACT OF THE THESIS
A Qualitative Study of Psychosocial Needs for Individuals with Lung Cancer
by
Kevin R. Criswell
Doctor of Philosophy, Graduate Program in Biochemistry
Loma Linda University, August 2012
Dr. Jason E. Owen, Chairperson
Lung cancer affects many people in the United States, accounting for 14.5% of
cancer cases in 2010. Additionally, it is responsible for more cancer-related deaths than
any other cancer type. Those living with lung cancer also experience a higher prevalence
of psychological distress and mood problems relative to most other cancer types. Despite
the high physical and mental health burden borne by those living with lung cancer,
psychosocial research on lung cancer generally lags far behind comparable studies in
other cancer populations. Evidence from the few interventions developed specifically for
lung cancer patients demonstrate an underutilization of those services, which is inferred
from generally low response rates from eligible participants. Although a low participation
rate may demonstrate the need to investigate the barriers of participating in interventions,
little research on that topic is currently available. Also, it is not clear what factors predict
refusal to participate in psychosocial interventions for the lung cancer population, despite
the available data on demographic and medical differences between eligible those who
did and those who did not participate. Overall, there is limited evidence available for
preferred interventions, for favored methods of receiving interventions (e.g., Internet,
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face-to-face, telephone), and for perceived barriers to access and maintain engagement in
available psychosocial interventions for lung cancer patients.
A qualitative study that utilizes a grounded theory approach to the analysis of
interview data from lung cancer patients can address the current gap in understanding of
lung cancer patients’ perspective on three specific areas: 1) the most important
psychosocial needs to address and what factors contribute to higher importance, 2)
interest in different psychosocial services and what factors contribute to low and high
interest, and 3) what factors serve as barriers to engage in psychosocial interventions.
Elucidating these three areas will increase researchers’ understanding of lung cancer
patients’ perspectives via the development of a grounded theory, which investigators can
utilize to better address the psychosocial and quality of life needs of this cancer
population.

xiii

CHAPTER ONE
BACKGROUND AND SIGNIFICANCE

Lung Cancer
Lung cancer is projected to be the most diagnosed cancer at 222,520 new cases in
the USA in 2010 (American Cancer Society [ACS], 2010). Responsible for an estimated
157,300 deaths in the U.S. in 2010, lung cancer has the highest mortality of any cancer
type (ACS, 2010). Out of 789,620 new cancer diagnoses for males and 739,940 for
females, cancer of the lung is estimated to be the second-most diagnosed cancer in men
(15%) and women (14%) in 2010 behind prostate (28%) and breast cancers (28%),
respectively (ACS, 2010).
Lung cancer can be separated into two major categories: non-small cell lung
cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC and SCLC are different in
their prevalence and mortality rate. NSCLC is more commonly diagnosed (85%) than
small cell lung cancer (14%) (ACS, 2010; combined percentage 99% due to rounding).
The five-year survival rate for patients with NSCLC (17%) is higher than patients
diagnosed with SCLC (6%).
Unfortunately, the five-year survival rate for lung cancer has remained at the
same low level from 1975 to 1986 (13%) with a slight increase between 1999 and 2005
(16%). This increase in survival is likely related to a combination of factors, which
include a decrease in overall smoking rates in the past 40 years and improved techniques
(e.g., spiral computed tomography scanning) for detecting lung cancer in early stages
within high-risk populations. However, it has been noted that evidence for the
contribution of advances in early detection techniques is still being collected and has not
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yet been proven to reduce mortality in lung cancer (ACS, 2010). When compared to the
national average across cancer types in 1999-2005 (68%), the five-year survival rate for
lung cancer is much lower. This difference can be attributed to a combination of factors
related to lung cancer diagnoses that are typically made at a late stage of the disease,
which can be due to such factors as ambiguous symptoms (e.g., an unusual cough) and
aspects related to lung cancer screening (e.g., not wanting a bronchoscopy; ACS, 2010;
Yardley, Davis, & Sheldon, 2001). Generally, a later stage of cancer implies that the
cancer has spread beyond the initial cancer site to the surrounding tissues or lymph
glands (regional stage) or metastasized to separate organs (distant stage). As the cancer
progresses to later stages, it becomes increasingly difficult to effectively neutralize the
cancer cells. Because only 15% of lung cancer cases are initially diagnosed at a local
stage (ACS, 2010), it is logical that the survival rate is low.

Risk Factors
Cigarette smoking has been determined to be the most salient risk factor for
contracting lung cancer. It has been demonstrated that the relative risk of developing
lung cancer increases with the duration and amount of the smoking. Although other
airborne substances (e.g., secondhand smoke, asbestos, talcum powder, and pollution)
have been found to contribute to the development of lung cancer, smoking cigarettes has
received the most attention from healthcare professionals and the public (American
Cancer Society [ACS], 2010). In their lifetimes, about 17.2 % of male and 11.6% of
female smokers (14.4%, combined) will develop lung cancer, and smoking behavior has
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been found to be attributable to about 90% of lung cancer cases (Alberg & Samet, 2003;
Villeneuve & Mao, 1994).

Psychosocial Issues in Lung Cancer
Several reviews have identified areas of psychosocial need in lung cancer, which
include quality of life, depression, distress, and smoking cessation. In addition to those
psychosocial issues, the constructs of stigma, self-blame, and guilt are gaining increasing
attention in the literature (Bedor, Alexander, & Edelman, 2005; Carlsen, Jensen,
Jacobsen, Krasnik, & Johansen, 2005; Joyce, Schwartz, & Huhmann, 2008). Although
stigma has been documented across cancer types, it seems lung cancer patients
experience more perceived cancer-related stigma relative to breast and prostate cancer
patients (Loconte, Else-quest, Eickhoff, Hyde, & Schiller, 2008); stigma in lung cancer
may also serve as a barrier to seeking care when symptoms of the disease are first
detected by the patient (Chapple, Ziebland, & McPherson, 2004). Self-blame and guilt
were documented in the experiences of lung cancer patients, yet levels of these constructs
seem to be explained more by a history of smoking than being diagnosed with a specific
cancer type (LoConte et al., 2008). However, levels of self-blame and guilt is likely to be
high in lung cancer patients because about 90% of all lung cancer cases can be attributed
to a history of smoking (American Cancer Society [ACS], 2010).
When compared to other cancer types, lung cancer patients have experienced
relatively greater levels of unmet need (Li & Girgis, 2006) and higher levels of
psychological distress when compared to other cancer types (Zabora, Brintzenhofeszoc,
Curbow, Hooker, & Piantadosi, 2001). In an investigation using United States

3

population-based data, individuals diagnosed with lung cancer, female reproductive
cancer, other, and multiple cancer diagnoses demonstrated the highest levels of distress,
as measured by the Kessler-6 (Kaiser, Hartoonian, Owen, 2010). In an investigation of
significant independent correlates of high levels of supportive care needs in a sample of
lung cancer patients, higher levels of need were associated with greater trauma, greater
symptom burden, lower satisfaction with health care, and lower levels of physical
functioning (Sanders, Bantum, Owen, Thornton, & Stanton, 2010). As a subpopulation
of cancer patients who demonstrate relatively high levels of poor psychosocial outcomes
related and high levels of unmet needs, it has been important to meet those needs with
interventions that are tailored for lung cancer patients (Carlsen et al., 2005).
This review of the current state of the literature on psychosocial needs and
interventions for lung cancer patients will focus primarily on quality of life, distress,
depression, anxiety, smoking, and the cluster of stigma, self-blame, and shame. Since
fatigue has also been identified as an important symptom with psychosocial implications,
its prevalence will be provided as well. First, the prevalence of each psychosocial issue
will be presented, followed by theories utilized to guide studies in this area of the
literature, the needs related to the psychosocial issues discussed, interventions
implemented to address those needs in samples of lung cancer patients, and barriers to
engage in available psychosocial interventions.

Prevalence of Psychosocial Issues
Generally, lung cancer patients and survivors have demonstrated high rates of
clinically relevant psychosocial issues. Unfortunately, the assessment of prevalence rates
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in study samples is often hindered by the absence of clinical cutoffs for scales used.
Characterizing psychosocial issues in lung cancer is further complicated by the utilization
of different measurements of constructs and behaviors across studies.

Quality of Life
Quality of life (QoL) has been defined as a multidimensional construct,
encompassing the physiological, psychological, and social wellbeing of a given
individual (Fox & Lyon, 2006; Yang, 2009). Examples of multidimensional scales used
to measure quality of life in lung cancer studies include the European Organization for
Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30;
Bezjak et al., 2008) and the Functional Assessment of Cancer Therapy – General Version
(FACT-G; LoRusso et al., 2003). Both of these measures have lung cancer-specific
modules, called the QLQ – Lung Cancer 13 (QLQ-LC13 and the FACT – Lung Version
(FACT-L), that encompass the impact on QoL from symptoms and treatments that are
typical for lung cancer patients (LoRusso et al., 2003). These additional modules add a
symptom and treatment burden component to the measurement of QoL that can provide a
useful perspective in explaining how QoL is related to relevant study variables when
sampling lung cancer patients. It should be noted that these scales differ slightly in their
assumption of the facets that compose QoL. Specifically, the QLQ-C30 is designed to
encompass five functional domain facets (i.e., Physical, Role, Social, Emotional, and
Cognitive). The FACT-G has four factors of wellbeing (i.e., Emotional, Cognitive,
Social, and Physical), which may be similar to the factors of the QLQ-C30. However, it
is unclear how these different scales differ with respect to convergent and divergent
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validity with other psychosocial outcome measurements, and future studies are needed to
determine whether these scales differ in their results across different subgroups of lung
cancer patients (e.g., separated by lung cancer type and stage of cancer) and settings.
Although QoL was defined as a multidimensional construct and measured using
scales that encompass multiple facets of QoL, some studies used single-item measures of
QoL (Gooneratne et al., 2007), possibly undermining the generalizability of their findings
to other studies that implemented valid measures of the multidimensional construct of
QoL. It is certainly preferable to use a measure that reflects the multifaceted
conceptualization of QoL along with items that are specific to the treatment because
those measurements have been shown to be valid and reliable (Casañas i Comabella,
Gibbons, & Fitzpatrick, 2010).
Comparisons of QoL measures between studies are complex, given the different
measurements of the construct used by different investigators. For example, some studies
have utilized measures that have been considered to be more general scales of overall
well-being (e.g., QLQ-C30), whereas others have used scales more specific to lung
cancer symptomology (e.g., LCSS). Therefore, it is difficult to compare findings directly
between studies of QoL in lung cancer patients.
Also, the lack of generally accepted criteria for identifying low, moderate, and
high levels of QoL in validated measures makes it difficult to determine rates of lung
cancer patients who are considered to have a high or low level of QoL. However, efforts
(Slotman et al., 2009) were made to quantify levels of lowered QoL over time in SCLC
patients (N = 188) who decreased at least 20 points (i.e., clinically relevant decrease)
from baseline to three months (according to the QLQ-C30) across factors included in the
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scale. Rates of clinically relevant decreases in QoL subscales were as follows: 28.7% for
global health status, 30.3% for role functioning, 16.5% for cognitive functioning, and
17.0% for emotional functioning. Future investigations should incorporate similar
methods of quantifying clinically significant levels of QoL to aid reviews of the literature
on overall wellbeing in lung cancer patients.
Generally, longitudinal studies of QoL in lung cancer patients show decreases in
the various domains of the underlying construct. Although a small subsample of SCLC
patients (n = 37) who received intravenous chemotherapy experienced a decline in role
functioning over time (Naughton et al., 2002), this finding involved a small sample and is
limited to a specific treatment and lung cancer type. Future longitudinal investigations of
QoL in lung cancer should involve large, nationally-representative samples to bolster the
generalizability of results. Although it is not clear as to exactly how great the level of
need for QoL interventions is due to the lack of generally-accepted cutoff criteria for
sequential levels of the multiple facets of overall wellbeing, the available literature does
suggest that lung cancer patients who demonstrate a low performance status, dyspnea,
and weight loss (Langendijk et al., 2000) will likely have a higher level of needs related
to QoL issues.

Distress
Distress is understood to be a multidimensional construct that incorporates
essentially any distressing area of a cancer patient’s life (Graves et al., 2007). Distressing
areas of the life may include physical health, effects of disease and treatment, and
difficulty in social and emotional domains. Interestingly, with such an encompassing
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definition, measurements of distress have included combinations of depression and
anxiety levels (Hospital Anxiety and Depression Scale), multiple domains of overall
distress (Brief Symptom Inventory), and simple one-item Likert scale measures (Distress
Thermometer) to assess the dynamic construct (Graves et al., 2007).
Increases over time in rates of clinical distress have been found in samples of lung
cancer patients. In a sample of lung cancer patients, 29% (n = 52) at baseline, 33% (n =
40) at three months, and 35% (n = 33) at six months were found to meet cutoff criteria for
clinically significant levels of distress (Badr, Acitelli, & Taylor, 2008). In a large sample
of mixed cancer diagnoses (N = 4496), lung cancer patients (n = 629) achieved the
highest rate of clinical distress (as measured by the Brief Symptom Inventory) compared
to all other cancer types in the sample (43.4%; Zabora et al., 2001). A larger rate of
clinical distress (61.6%) was found in distress screening study of lung cancer patients (n
= 333; Graves et al., 2007). However, this study noted that 134 of the study sample had
not received a definitive diagnosis of lung cancer, potentially undermining the results.
Evidence has been found for increased severity of distress over time (Aubin et al., 2010),
but small sample sizes limit the validity of this finding.

Depression
Some studies consider depression to be a multidimensional construct that is
manifested through bidirectional interactions between biological, psychological, and
social variables (i.e., the biopsychosocial model is inferred to conceptualize the role of
depression; Lo et al., 2010). Other studies have adhered closely to the conceptualization
of depression set forth by the Diagnostic and Statistical Manual of Mental Disorders
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(Spitzer, Williams, Gibbon, & First, 1990) third ed., revised criteria that was current at
the time of the study (Nakaya et al., 2006; Uchitomi et al., 2003). However, large
discrepancies between rates of clinically significant depression have developed between
using the Structured Clinical Interview and other validated measurements, such as the
Center for Epidemiological Studies Depression Scale (CES-D), the Beck Depression
Inventory (BDI) and the Hospital Anxiety and Depression Scale (HADS).
Using the CES-D cutoff, 33-38.9% of lung cancer samples met the cutoff for a
clinically significant level of depressive symptoms (Gonzalez & Jacobsen, 2010;
Hopwood & Stephens, 2000; Kurtz, Kurtz, Stommel, Given, & Given, 2002). A slightly
lower rate of depression (28.6% of n = 119) was found in a sample of early-stage female
NSCLC patients (Sarna et al., 2010). Interestingly, a similar prevalence of severity of
depressive symptoms (30%) has been found in a sample of spouses of lung cancer
patients (Kim, Duberstein, Sorensen, & Larson, 2005). Other studies have reported much
lower prevalence rates for the presence of clinically significant depression in lung cancer
patients (between 4.7-8%), which is likely due to using the Structured Clinical Interview
for the DSM-III-R (SCID) to assess for depression and to being a Japanese sample
(Nakaya et al., 2006; Uchitomi et al., 2003). Also, low rates of depression in lung cancer
samples have been found when using the strict criteria of “definite depression” when
using the HADS scale (3%; Myrdal, Valtysdottir, Lambe, & Ståhle, 2003). LoConte et
al. (2008) found a significant inverse quadratic trend in depressive symptom severity over
time in a subsample of lung cancer patients (n = 52), with the highest levels seen at two
months since the start of the study when using the depression subscale of the HADS. It
should be noted that the LoConte et al. study limited the sample to stage IV NSCLC
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patients. It is possible that that finding was spurious due to the absence of significant
quadratic trends being found in other longitudinal studies of depression in lung cancer
(Hopwood & Stephens, 2000). However, trends of increasing severity of depressive
symptoms over time have been found (Henoch, Bergman, Gustafson-Johansson, &
Danielson, 2007), suggesting a linear increase in depression in lung cancer patients over
time. However, When nearing the end of life at advanced stages of lung cancer, it has
been demonstrated that a significant quadratic relationship exists between levels of
depression and time to death, where depressive symptoms are at their lowest level of
severity at 20 months until death and steadily increase in a curvilinear fashion toward
time of death (Lo et al., 2010). However, this finding has not been replicated in other
longitudinal studies that have included depression measures.
There is evidence that levels of depression are positively related to mortality in
lung cancer (Buccheri, 1998; Chen, Chen, & Yu, 2010). However, this finding has been
debated in the literature with null findings from other studies (Nakaya et al., 2006). It is
possible that lung cancer patients who adopt a depressive coping strategy and have lower
performance status have a shorter life-expectancy (Faller & Schmidt, 2004), indicating
that it may not simply be the presence of depressive symptoms that predicts shorter
survival (depression levels as measured by the HADS depression subscale was not a
significant predictor of survival time in the same study). It is also possible that the
contradiction in findings reflects the unknown longitudinal relationship between
depression, symptom burden, and survival. Clearly, rigorous longitudinal studies that
investigate survivorship in lung cancer patients need to be conducted.
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Anxiety
Studies that have included anxiety in investigations of psychosocial aspects of
lung cancer have not explicitly defined anxiety. It can be inferred from the frequent use
of specific scales (e.g., the Hospital Anxiety and Depression Scale) that anxiety is
considered to be a facet of overall distress. This anxiety refers to subjective feelings of
worry that give rise to pathological levels of clinical distress.
Myrdal et al. (2003) found that 43% of the sample of lung cancer patients (n =
112) met the cutoff for possible clinical anxiety (as measured by the HADS). Using the
same measurement, a lower percentage of the lung cancer sample met the criteria for
definite clinical anxiety in another study (16% of 82 lung cancer patients; Montazeri,
Gillis, & McEwen, 1998). In the same investigation, lung cancer patients did not vary
significantly over time with respect to levels of anxiety from baseline to three months
later, suggesting a low level of anxiety over time. However, findings from another
investigation of anxiety in lung cancer patients (N = 170) suggested that 43.3% of their
study sample reported clinically significant levels of anxiety (as measured by an authorconstructed scale; Buchanan, Milroy, Baker, Thompson, & Levack, 2010). Another
study found that 25% of the lung cancer sample (n = 250) met the cutoff for clinically
high levels of anxiety (as measured by the Brief Symptom Inventory, BSI;
Tchekmedyian, Kallich, McDermott, Fayers, & Erder, 2003).

Fatigue
Often considered one of the most commonly reported symptoms by lung cancer
patients and survivors, fatigue has been conceptualized as a distressing and subjective
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feeling of a lack of energy, tiredness, and loss of physical strength. Rates of fatigue in
lung cancer are generally at or slightly above half of study samples, ranging from 50-59%
(Hung et al., 2011; Okuyama et al., 2001; Stone, Richards, A’Hern, & Hardy, 2000).
However, one study by Hickok, Morrow, McDonald, and Bellg (1996) reported that over
three-quarters (78%) of the study sample of lung cancer patients who received
radiotherapy demonstrated clinically relevant levels of fatigue, but this finding is
questionable due to the retrospective nature of the methodology, using patients’ past
medical record to assess for fatigue. One study defined “severe fatigue” as the 95th
percentile of scores obtained on the Fatigue Severity Scale (FSS) by an age and gendermatched sample of control subjects without cancer (Stone et al., 2000). However,
another study defined “clinical fatigue” as fatigue that interfered with at least one aspect
of daily functioning, which may be considered more inclusive when compared to Stone et
al. (2000). Certainly, efforts need to be made to standardize measurements and generally
recognized clinical cutoffs for fatigue.

Smoking
Studies have typically differentiated between current (i.e., currently smoking at
the time of the study), former (i.e., did not smoke at the time of the study but did smoke
before), and never smokers (i.e., never smoked before or during the time of the study).
Former smokers tend to make up the majority of the study samples (37-80.2%), whereas
current (11.5-50%) and never (8.3-13%) smokers composed smaller fractions of study
samples (Balduyck et al., 2011; Gonzalez & Jacobsen, 2010; LoConte et al., 2008).
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Estimates of relapses in smoking post-treatment have varied widely (30-60%; Pinto,
Eakin, & Maruyama, 2000; Walker, Larsen, Zona, Govindan, & Fisher, 2004).
Measurements of smoking behavior vary across studies. Some investigators
seemed to choose their measures based on a model under scrutiny, such as a model
consisting of smoking urges and social support (Walker et al., 2004). Studies have also
used author-created questionnaires to determine current smoking status, age of first
tobacco use, and number of pack years (i.e., the number of packs smoked in one day
multiplied by the number of years as a smoker) of study samples. Some studies have also
used biological indicators of smoking status at the time of the study (e.g., urinary
cotinine; Cooley et al., 2007), using the biological markers as indicators of smoking
status when discrepancies exist between self-report questionnaires and the biological
indicators. Clearly, a consensus on how to measure smoking behavior in lung cancer has
not been reached. These differences in measurement may be partly to blame for the
variability in reported smoking rates in the literature.
Primary prevention of smoking behavior can substantially decrease the prevalence
and mortality due to lung cancer because 90% of the cases of lung cancer can be traced to
the use of tobacco (Alberg & Samet, 2003). Despite a history of smoking, studies have
shown that cessation of smoking behavior can reduce the probability of contracting lung
cancer, having a recurrence of cancer, or dying from the disease (Anthonisen et al., 2005;
Wu & Sin, 2011). With the steeper decline seen in tobacco use in men compared to
women from 1997 – 2006 (Jemal et al., 2008), lung cancer mortality has been declining
at a greater rate for men than for women. If such a trend were to continue, women may
surpass men in the number of cancer deaths. In summary, lung cancer patients
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demonstrate a need for interventions aimed at ceasing the use of tobacco, especially in
female lung cancer patients with a history of smoking.

Stigma and Self-Blame
Some lung cancer patients attribute the cause of their cancer to their behavior
(Faller, Schilling, & Lang, 1995) and experience feelings of being labeled as “dirty” or
“undesirable” (Chapple et al., 2004) because of their identity as lung cancer patients.
Stigma has been conceptualized as a normative label (Menec & Perry, 1995) that implies
an undesirable or flawed quality. This label can be externally imposed by others; in the
case of the lung cancer patient, others might assume that the individual smoked, which
contributed to the development of the cancer. In this way, lung cancer patients may
perceive that others blame them for their disease. In one investigation, stigma was
conceptualized in lung cancer as “health-related stigma,” which is a subjective experience
of rejection or devaluation based on an identifiable label stemming from a healthcondition (e.g., the label of “lung cancer patient or survivor” and being rejected due to
that connection with the chronic health condition; Cataldo, et al., 2011). Interestingly,
inherent in most investigations of stigma is the concept of self-blame for contracting the
disease, whether the feeling was imposed by the stigma from others or stemmed from
personal thoughts or feelings (Faller et al., 1995; Chapple et al., 2004; Cataldo et al.,
2011).
Self-blame (also, personal blame) has been considered as attributing personal
responsibility for a given condition (e.g., contracting lung cancer; Faller et al., 1995).
Not as often studied as stigma, self-blame has been clustered together with stigma
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(Chapple et al., 2004), More research is needed to establish whether self-blame should be
studied separately from stigma or if self-blame should be always included in
investigations of stigma in lung cancer.
Measurements of stigma and self-blame in lung cancer patients vary across
studies, making it difficult to compare results. Complications in interpreting results of
studies arise from the low availability of measurements that have demonstrated validity in
lung cancer patient samples. The Cataldo Lung Cancer Stigma Scale (CLCSS) is the
only measure of cancer-related stigma that was normed on a sample of lung cancer
patients (Cataldo et al., 2011). Four subscales are in this measure: 1) stigma and shame,
2) social isolation, 3) discrimination, and 4) smoking. Other measures of stigma, selfblame, and guilt include the Social Impact Scale (SIS; Gonzalez & Jacobsen, 2010), the
State Shame and Guilt Scale (SSGS), and the Perceived Cancer-Related Stigma Scale
(PCRS; LoConte et al., 2008).
Quantifying the rate of lung cancer patients who experience a clinically
significant level of stigma or self-blame has begun recently with the availability of
measures to assess such constructs (e.g., Cataldo et al., 2011). Implying self-blame, 70%
of lung cancer patients (while 63% indicated on a questionnaire in the same study) who
were interviewed attributed their smoking behavior as a cause of their lung cancer (Faller
et al., 1995). However, this statistic must be compared to quantitative stigma data
gathered in future studies of lung cancer samples. Although, no studies have utilized
cutoff scores to separate more severe from less severe cases of stigma, self-blame, and
shame, one study demonstrated that patients with NSCLC experienced a significantly
higher level of perceived cancer-related stigma relative to breast and prostate cancer
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patients, but blame and guilt averages did not differ across cancer groups (LoConte et al.,
2008). Interestingly, blame and guilt scores were predicted by having a history of
smoking and not by type of cancer.

Interventions Offered to Address Psychosocial Needs
Available literature documenting the effectiveness of psychosocial interventions
for lung cancer patients is lacking in comparison to the high level of psychosocial need in
this cancer population. Interventions have focused mainly on reductions in distress,
cessation of smoking, and increase in QoL. No literature was found on psychosocial
interventions that target anxiety; depression; and stigma, self-blame, and shame in lung
cancer patients.
The effectiveness of interventions targeting psychosocial issues in lung cancer is
mixed: Interventions aimed at smoking cessation show little or no intervention effects;
yet QoL, dyspnea (Bredin et al., 1999), and distress interventions generally show
improvements in the outcomes measured. For example, a combination supportive care
and chemotherapy intervention resulted in longitudinal improvements in social and global
QoL (Helsing, Bergman, Thaning, & Hero, 1998). Also, a QoL screening intervention
and early palliative care resulted in more discussion about QoL issues that concerned
lung cancer patients (Jacobsen et al., 2011; Taenzer et al., 2000; Temel et al., 2010).
Finally, rates of clinically significant distress (as measured by the DT) were shown to be
significantly lower in a group who received an extensive distress screening in addition to
a referral to talk with a member of a psychosocial team (30.7%), when compared to two
other groups who received either the more extensive distress screening (50.9%) or the
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minimal screening (51.3%; Carlson, Groff, Maciejewski, & Bultz, 2010). Given the
prevalence rates for depression; anxiety; fatigue; and stigma, self-blame, and guilt, it is
necessary to develop interventions that effectively target those psychosocial issues.
Additionally, areas of improvement should be identified for interventions delivered (e.g.,
targeting smoking behavior) to increase the treatment effects.
Response rates have also varied across intervention trials. Some have reported
perfect response rates, and other studies have not reported any response rate for lung
cancer patients who participated (Bredin et al., 1999; Helsing et al., 1998; Temel et al.,
2010). However, the response rates for most interventions that target improvement of
psychosocial outcomes in lung cancer are in the range of 33.5-53.3% (Jacobsen et al.,
2011; Porter et al., 2011; Taenzer et al., 2000). Clearly, the literature on psychosocial
interventions for lung cancer patients suffers from a lack of reporting the response rates
of trials. Since most interventions that include the response rate indicate that about half
or fewer eligible lung cancer patients participate, the development of future interventions
may benefit from a qualitative investigation regarding the reasons why lung cancer
patients decide to not take part in supportive care services offered to them. Gaining
insight into the perspective of the lung cancer patient can help direct future development
of research studies to be tailored more effectively to the needs and preferences of the
target population.
In summary, lung cancer patients have a high level of need in multiple
psychosocial domains, yet it is unknown why eligible patients tend to not participate in
intervention trials. It is evident that most lung cancer patients are interested in at least
one form of supportive care service (91.4%) and about 20% were interested in attending a
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lung cancer support group (Sanders, Bantum, Owen, Thornton, & Stanton, 2010).
However, Owen, Goldstein, Lee, Breen, & Rowland (2007) found that only .03% (n = 5)
of lung cancer patients utilized a cancer-related support group. Because most (92.2%) of
those patients perceived benefit from attending a cancer-related support group,
understanding the barriers to access and maintain engagement in interventions can lead to
higher rates of utilization of supportive care services that patients typically perceive to be
beneficial.

Barriers to Access and Maintain Engagement in Psychosocial
Interventions
Very little research has been dedicated to exploring the reasons why lung cancer
patients might experience difficulty in accessing and maintaining engagement in
psychosocial interventions developed for their needs. With the exception of one
investigation of the difference between lung cancer patients’ and support group
facilitators’ perceptions of barriers to access a support group (Devitt et al., 2010), no
research has been conducted on this topic for lung cancer. Although it is likely that
factors such as high symptom burden, mortality, and not meeting eligibility criteria can
contribute to hindering lung cancer patients’ involvement in psychosocial interventions,
such hypotheses have yet to be systematically tested.
Results from qualitative research suggest several potential barriers to accessing
and maintaining engagement in interventions. For example, a lung cancer patient
reported that she feared that she would be refused cancer treatment because she was a
smoker (Chapple et al., 2004). Also, there is some evidence that stigma and self-blame
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may be related to social isolation (Greene & Banerjee, 2006), indicating that lung cancer
patients with high levels of personal blame may tend to not seek help for unmet needs.
Finally, Devitt et al. (2010) found that lung cancer patients perceived the group
environment, discussing their cancer, parking, and travel as potential barriers to access a
support group. However, further evidence must be gathered to better understand what
drives lung cancer patients’ decisions about participating in available interventions.
Ideally, an in-depth analysis of lung cancer patients’ difficulties to access and maintain
engagement in interventions would inform the development of interventions, improving
the response rates of services offered.

Theories Used to Guide Investigations of Psychosocial Issues
Overall, the literature on psychosocial issues in lung cancer is lacking guidance
from theoretical frameworks in the areas of anxiety, distress, and quality of life.
Although theories have been found to guide investigations in other psychosocial
constructs, they often vary widely in their usage and focus on different outcome
variables, complicating comparisons of results across studies. Investigations of distress
and anxiety did not report the use of any theoretical models to guide aims and
hypotheses.

Quality of Life
Several studies did not identify a theory or model that guided investigations and
interventions involving QoL in lung cancer patients (Helsing et al., 1998; Langendijk et
al., 2000; Taenzer et al., 2000; Naughton et al., 2002). Generally, theoretical orientations
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are lacking in investigations of QoL, providing little direction for study hypotheses and
aims, which are often chosen based on previous research that suffers from multiple
shortcomings already discussed. One investigation highlighted the lack of theoretical
orientations used in the psychosocial literature in lung cancer, stating, “With limited
theoretical perspectives available, researchers also must turn to the empirical literature for
guidance in study efforts in this important and emerging field” (Fox & Lyon, 2006; p.
932). Within this same investigation, the authors incorporated a relatively young
“theory” that they named “the theory of unpleasant symptoms,” which considers the
importance of identifying “symptom clusters” as units of analysis when testing their
effects on other outcome measurements. The use of the model yielded results from a
hierarchical “symptom cluster” of depression and fatigue explaining QoL scores (n = 52),
which concluded with depression explaining a significant amount of the variance and
fatigue dropping from significance. Although this result did not provide novel findings,
further investigations utilizing this approach along with larger samples and many
different, widely used, and valid measurements may help guide future investigations.
Theories that incorporate QoL as a factor within their frameworks should be applied
more often in the literature to guide hypotheses and conclusions drawn from results.

Depression
No theories or models were applied in several studies (Hopwood & Stephens,
2000; Kurtz et al., 2002). However, one study inferred the use of the biopsychosocial
model to understand the complexity by which depressive symptoms are manifested and
maintained in lung cancer patients (Lo et al., 2010), emphasizing the multitude of factors
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that should be considered in predicting depression. Also, other investigations have used
attachment and hope theories.
Attachment theory has been utilized to demonstrate that individuals with chronic
illnesses who have not developed healthy expectations of and capacity for social
relationships will likely demonstrate higher levels of depression. Within this framework,
investigators (Lo et al., 2010) saw the importance of keeping the integrity of the self in
the context of advanced cancer, which may help foster higher self-esteem and buffer
against depressive symptoms. However, a major limitation in the current use of this
theory in lung cancer is the lack of longitudinal data from childhood to corroborate
patient self-report of one’s attachment to a primary caregiver. Although it may be
assumed that relationships between the patient and significant others might characterize
the patient’s quality of attachment early in childhood (a presupposition of this theory),
this assumption should be confirmed for this population.
Also, Hope Theory (Snyder, 2002) was applied to a study of depression in lung
cancer patients, predicting higher levels of depressive symptoms with lower levels of
hope (as measured by the Adult Hope Scale; Berendes et al., 2010). Hope Theory is a
goal-attainment theory, conceptualizing individuals with high levels of “hope” as those
who can perceive a greater number of methods to obtain a desired goal (i.e., pathways
thinking) and consider themselves as highly capable of pursuing a goal via the perceived
pathways to the goal (i.e., agency thinking). It was found that depressive symptom
severity was inversely related to levels of hope, implying higher levels of hope predicted
lower levels of depressive symptomology. The authors (i.e., Berendes et al., 2010) called
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for further longitudinal research to investigate whether levels of hope continue to predict
levels of depression across multiple timepoints.

Smoking
A model incorporating Appetitive (i.e., desiring positive effects as a result of a
behavior) and Aversive (i.e., engaging in a behavior to avoid negative feelings or
consequences) urges as well as Directive and Nondirective social support was
constructed by Walker et al. (2004) to explain smoking relapse in lung cancer patients
who completed treatment for cancer. The theory posits that individuals who did smoke
will likely relapse into smoking again if an individual has a high reactance (i.e., a
tendency to reject or oppose advice given from others) and experiences directive social
support (i.e., advice characterized by being told what to do and giving little choice to the
recipient of the support) will likely experience high levels of appetitive urges, leading to
higher relapse rates as well as higher levels of depression. Although Walker et al.’s
(2004) findings supported the theory, a low sample size (n = 35) and lack of replication in
the literature raises questions regarding the strength of the theory and its validity in
predicting smoking behavior.

Stigma and Self-Blame
Several studies have guided study hypotheses via attribution theory to explain
lung cancer patients’ reactions to stigma and self-blame in mixed methods (Faller et al.,
1995) and cross-sectional quantitative research. Menec’s and Perry’s (1995) study was
helpful in providing information regarding the feelings of anger, pity, responsibility, and
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willingness of individuals without chronic illnesses (i.e., N = 249 introductory
psychology students at a Canadian school) to provide aid to younger or older individuals
of 10 selected “stigmas” (i.e., conditions that are considered undesirable or generally
looked down upon by society). As lung cancer was included as one of these stigmas, the
study provided an opportunity for researchers to understand how an educated population
of young adults (mostly female) viewed young and old individuals with lung cancer,
based on level of controllability (i.e., whether the individual with the stigma was able to
influence its etiology). The results suggested that older lung cancer patients were viewed
with significantly more pity and evoked less anger than younger lung cancer patients.
However, the effect of controllability predicted more pity, less anger, less attribution of
responsibility, and more willingness to help for lung cancer patients who had scenarios
that depicted an uncontrollable condition. The results of this study were corroborated by
a qualitative study (Chapple et al., 2004), which demonstrated that older lung cancer
patients did report feeling no blame from others more often when compared to younger
lung cancer patients in the study and that others viewed their illness as attributable to
their smoking (i.e., a controllable behavior), even if a patient was never a smoker.
Faller et al. (1995) used attribution theory to explain that lung cancer patients
typically attribute the cause of their disease to smoking, implying self-blame and
initiating a search for ways to reduce cognitive dissonance (i.e., Lung cancer patients see
that they are to blame for their illness due to their smoking behavior, yet they can readily
identify other causes for their illness as well, placing less of the blame on themselves and
reducing dissonance.). For example, although 70% (when interviewed; 63% reported via
questionnaire) of the lung cancer patients in the study sample identified smoking
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cigarettes as a cause (implying their own behavior was to blame), 41% of the sample
stated that the cause of their lung cancer was not known, suggesting that the placement of
causal attribution on uncertainty is a method of dissonance reduction. Although this
theory seems promising in predicting psychosocial adjustment to lung cancer from causal
attributions, there is little research with adequate sample sizes and quantitative measures
validated on samples of lung cancer patients to test the assumptions of this theory in lung
cancer populations.
Besides attribution theory, Modified Labeling Theory guided an investigation of
the relationship between stigma and depression in a sample of lung cancer patients
(Gonzalez & Jacobsen, 2010). The theory predicts that lung cancer patients tend to
blame themselves for their cancer because society has linked lung cancer so strongly with
tobacco use, which is a controllable behavior. Therefore, self-blame predicts depression
in lung cancer patients.
In the development of the CLCSS, Cataldo et al. (2011) applied a model of
health-related stigma to conceptualize the effects of social attitudes towards lung cancer
and perception of personal identity as a lung cancer patient, which leads to negative
physical and emotional reactions as well as a restructured worldview. This relationship is
mediated by the lung cancer patient’s awareness of aspects of stigmatization, which may
include social disqualification, limited opportunities, and negative change in identity.
Other studies did not report a theoretical orientation. These studies appeared to be
exploratory. Studies were either qualitative investigations of experiences of lung cancer
patients (Chapple et al., 2004) or studies guided by previous findings in the literature
(LoConte et al., 2008).
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Summary of Psychosocial Needs, Interventions, and Barriers to Engage in
Interventions
Overall, the available literature indicates that lung cancer patients generally have
high levels of need for relief from depression, anxiety, and psychosocial distress. The
use of scales with cutoffs for clinically relevant levels of symptom severity for those
constructs have helped to establish how great the level of those psychosocial needs is.
Although it is evident that lung cancer patients have psychosocial needs related to
different psychosocial and physical issues, it can be difficult for literature reviews to
characterize how high the levels of those needs are and how they relate to study variables
due to the use of different measurements across studies, a large diversity theories or lack
thereof to guide investigations, the absence of criteria for clinically relevant levels of a
given construct as measured by scales, and findings that conflict or are not replicated
across studies.
Although it is evident that QoL issues, stigma, self-blame, and smoking behavior
also represent domains of psychosocial needs for lung cancer patients, it is unclear how
high the level of needs is due to high heterogeneity of measurements used across studies,
and the lack of clear cutoffs or criteria for clinically significant levels of a given
construct. Future studies should be conducted to determine criteria for low, moderate,
and high levels of these constructs to facilitate the quantification of clinically significant
levels of specific constructs in lung cancer patients.
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Lung Cancer Patients’ Experience of Psychosocial Needs
Based on current literature regarding psychosocial needs of lung cancer patients,
there is not a clear understanding of the etiology of lung cancer patients’ needs, the
predictors of higher levels of needs in a given psychosocial domain (e.g., predictors of
depression), and what psychosocial needs lung cancer patients consider to be most
important to them. Despite the available results from independent investigations, it is
unclear as to the development of specific psychosocial needs of lung cancer patients due
to the use of multiple theories within the same domain of psychosocial need as well as
methodological shortcomings that often limit interpretations of study findings.
The results found in psychosocial literature on lung cancer research are often
undermined by small sample sizes, the use of different measurements and
conceptualizations of the sane construct, and the use of different or no theoretical
orientations. These shortcomings limit the generalizability of findings across studies,
resulting in no clear model, or theory as to the development of any one domain of
psychosocial needs in lung cancer. Further complicating the integration of the findings
between studies is the lack of use of procedures to control for Type I error. Few studies
reported the use of such techniques like the Bonferroni correction (Naughton et al., 2002)
to lower the probability that spurious findings will be reported as significant. Altogether,
findings from investigations of psychosocial needs of lung cancer patients are presented
with few clear conclusions that can be drawn when one reviews the available literature.
Qualitative studies are certainly more numerous in the psychosocial cluster of
stigma, personal blame, and shame in lung cancer patients, which may help explain how
investigations in this domain are set in the context of theories (e.g., attribution theory)
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more often than other investigations within other domains of psychosocial needs in lung
cancer patients. Certainly, it seems that early studies by Faller et al. (1995) and Menec
and Perry (1995) helped establish the use of theories in investigations of stigma and selfblame, which later studies by Cataldo et al. (2011) and Gonzalez and Jacobsen (2010)
continued. Future studies that utilize a qualitative methodology to gather and analyze
interview data may be beneficial to help elucidate the experience of lung cancer patients
who have high levels of various domains of psychosocial needs.

Lung Cancer Patients’ Levels of Interest in Psychosocial Services
Little is known about lung cancer patients’ levels of interest in specific types of
psychosocial interventions and what factors predict interest levels. There is limited
evidence currently available that points to a majority of lung cancer patients in a study
sample who desire information about their disease and its treatment as well as exerciserelated information and support (Sanders et al., 2010). Low response rates from eligible
lung cancer patients may reflect several possible conclusions, such as a low interest in the
type of service or how it is delivered. A qualitative study of lung cancer patients’
perspectives regarding the preferred characteristics of psychosocial interventions may be
necessary to formulate hypotheses as to the reasons why low response rates are observed
in lung cancer-specific psychosocial interventions.

Barriers to Engage in Psychosocial Interventions
Across intervention studies involving lung cancer samples, there is generally low
response rates may indicate that there are significant barriers to engage in psychosocial

27

interventions. However, little research has been conducted to investigate this possibility.
Evidence is only available for barriers to access and engage in smoking cessation
interventions for smokers (Roddy et al., 2006) and for demonstrating a potential barrier in
significant discrepancies between perspectives of lung cancer patients and those who
facilitate supportive care services (Devitt et al., 2010). Overall, specific evidence that
elucidates the experience of lung cancer patients’ troubles in accessing psychosocial
interventions is lacking. This gap in the literature may be filled by a qualitative
investigation involving a sample of lung cancer patients and utilizing a grounded theory
approach, similar to the investigation conducted to explore smokers’ perspective
regarding barriers to access and maintain engagement in a smoking cessation intervention
(Roddy et al., 2006).

Developing Effective Interventions: The PRECEDE-PROCEED
Model
The PRECEDE-PROCEED model of intervention development will be utilized as
the context by which the proposed study will take place. It was chosen because it
considers a subjective assessment of the experience of the target population (i.e., the
individuals for whom an intervention’s effect is intended) as the first phase of a multistep process of developing effective interventions. Since the literature is lacking on
perspectives of lung cancer patients regarding how they experience psychosocial issues,
what psychosocial interventions interest them, and what barriers they perceive as
impeding their engagement in available interventions, a model that incorporates an
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assessment of the target population’s perception of their needs as a part of developing
effective interventions was an ideal framework in which the proposed study could be set.
The PRECEDE-PROCEED model has been used as a framework for building
effective psychosocial interventions (Green & Kreuter, 1999). The PRECEDEPROCEED Model of health promotion planning is considered “a theoretically ‘robust’
model that addresses a major acknowledged need in health promotion and health
education: comprehensive planning” (pp. 35-36). Numerous health departments,
randomized clinical trials, and other health projects have implemented PRECEDEPROCEED. Also, a variation of the PRECEDE-PROCEED model has been
recommended by the American Lung Association as a Program Planning and Evaluation
Guide for Lung Associations (L. W. Green, 1987). A brief description of the first two
phases of the model will illuminate a weakness that exists within the process of
development, implementation, and evaluation of psychosocial interventions that target
the population of lung cancer patients: Interventions are too often implemented without a
continuous subjective needs assessment of the participants involved. Indeed, Green and
Kreuter (1999) state that two foundational pieces of information for sound intervention
development are the subjective needs and the health problems of the target population.
Phase one and phase two of the PRECEDE-PROCEED model address the
subjective concerns of the target population (phase one) and allow those to inform the
ranking of relevant threats to health (phase two; Green & Kreuter, 1999). Although it
may be necessary for some health care professionals to develop programs without the
benefit of enough time or resources to begin an intervention assessment through
subjective evaluation by the target population, the concerns of patients should be a vital
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resource to help inform the dynamic growth of such programs throughout every phase.
Without the guide provided by the views of lung cancer patients, psychosocial
interventions may develop a myopic understanding of the entire context of health needs
(medical and psychological) that are most pressing in their minds. In her editorial
concerning the use of theory in health promotion, Green (2000) warned of the danger
inherent when health promotions are completely guided by amassing empirical data on
the effectiveness of given interventions. She argued, “Of more relevance to the
practitioner are general principles together with an understanding of context-specific
factors, which will allow adaptation to suit different situations” (p. 129). She posited that
the inclusion of such factors in the design and implementation of interventions would
help avoid “type III error,” which is defined as “the rejection of the effectiveness of a
programme when the programme itself was inadequate in terms of design or delivery” (p.
126). Essentially, attention must not only be placed upon the evaluation methodology,
but care is to also be taken in the development of quality psychosocial interventions.
In the case of lung cancer patients, it is then of great importance to ascertain
which psychosocial interventions they would consider most helpful. It is apparent that
investigators are delivering interventions that are either of little interest to lung cancer
patients or are delivered without regard to barriers that the target population perceives. In
light of the call for psychosocial interventions that are contextually relevant and
theoretically grounded, an assessment of the unique psychosocial needs of lung cancer
patients is necessary and has begun with such investigations by Sanders et al. (2010) and
Devitt et al. (2010).
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The Importance of the Target Population’s Perspective in Current
Lung Cancer Intervention Development
Carlsen and colleagues (2005) have discussed that lung cancer patients may
benefit from tailored interventions, which are specific to the socio-cultural context of the
target population (p. 299). Interventions that are constructed to mesh with the unique
backgrounds of diverse patient populations must be guided by subjective needs
assessments because different patient populations inevitably comprise different
composites of individual cultural backgrounds. As the PRECEDE-PROCEED model
suggests, the development of effective psychosocial interventions for lung cancer patients
must begin with an understanding of the needs that they consider to be most important.
As Carlsen and colleagues (2005) suggest, this may be accomplished through standard
psychosocial screening of lung cancer patients, which can provide a clearer picture of
which psychosocial interventions may prove to be most beneficial or should be offered.
Although Carlsen and colleagues (2005) make this suggestion for the purpose of
identifying lung cancer patients who are depressed and are at risk for depression, a
comprehensive psychosocial screening instrument can help identify an array of needs that
can be met with the appropriate intervention (Taenzer et al., 2000). This scenario (i.e.,
using a standard psychosocial screening instrument) may prove beneficial in healthcare
settings that already possess a wide array of available psychosocial services for cancer
patients. However, if novel psychosocial interventions need to be developed, then it
would be beneficial to conduct a subjective needs assessment, which can be comprised of
qualitative methods to capture in-depth patient perspectives. If a psychosocial
intervention is guided by the goal of meeting those pertinent needs, then the intervention
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will be more likely to demonstrate a higher level of effectiveness or efficacy, depending
on the setting of the intervention.

Study Aims
The study addressed the following three aims, which are stated as research
questions (Strauss & Corbin, 1998): 1) Which psychosocial needs do lung cancer patients
consider to be the most important, 2) what are the barriers that lung cancer patients
perceive as hindering them to engage in a psychosocial intervention, and 3) which
methods of delivering psychosocial interventions are most desired by lung cancer
patients? Since these questions address a poorly understood domain of the research
literature, and the focus of the study was rooted in the concerns (or perspectives) of the
subjects (Strauss & Corbin, 1998); the study utilized qualitative methodology – guided by
a grounded theory design – to explore how lung cancer patients perceive their
psychosocial needs, the psychosocial interventions that are available to them, and the
barriers that impede accessing and maintaining engagement in interventions.

Study Design
In an attempt to understand the psychosocial needs of lung cancer patients and
how healthcare professionals can meet those needs, a qualitative design guided the
research process for this study (Strauss & Corbin, 1998). Akin to other studies that
utilized a grounded theory approach (e.g., Badr & Taylor, 2006), the study analyzed the
qualitative data gathered with the goal of deriving an explanation that addressed the aims
of the study. Since grounded theory (GT) designs have been utilized to compose a theory
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of processes common across the subjects involved in the study (Creswell et al., 2007), the
proposed study implemented a GT design to elucidate shared phenomena across the lung
cancer patients that will be included in the study.
The GT approach was implemented to guide the investigator towards a theory that
will emerge from the qualitative data. As grounded theory is an approach that begins
with the collection of data, which is then followed by immersion into the data and the
subsequent emergence of theory, Strauss and Corbin (1998) describe the proper approach
to carrying out studies that implement a grounded theory design.
Using the grounded theory approach to analyze the qualitative data, it was
imperative for the investigators to examine the subjects’ responses without projecting
personal perceptions or biases regarding the actual content of the responses or the theory
that will be built at the conclusion of the study. Although they admit that absolute
objectivity is impossible, Strauss and Corbin (1998) emphasized the importance of
objectivity during a qualitative analysis of the data, especially within a study that is
guided by the grounded theory design. When focusing on the concerns of the subject, it
was crucial to design and deliver the interview schedule from a neutral orientation, which
is not influenced by heuristic knowledge or expectations regarding the theory that will
emerge. If an investigator approached the data with biases (e.g., about the nature of the
subjects or the theory that is expected to emerge) that influence the development of the
interview schedule and interactions with the subjects, then it would be likely that the
emergent theory will not accurately reflect the perspective of the subjects. With the
importance of objectivity in viewing the data at the forefront of the investigator’s
concern, the study was approached with a GT design.
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CHAPTER TWO
METHOD

Subjects
Since the theoretical population for this study will be lung cancer patients in the
USA, a sample of lung cancer patients was recruited from the accessible population of
lung cancer patients who were registered in the Loma Linda University Medical Center
(LLUMC) cancer registry (i.e., the sampling frame). The investigators decided to sample
from the LLUMC cancer registry because the lung cancer patients who are found in the
cancer registry are thought to be representative of lung cancer patients treated at cancer
centers throughout the United States.
The investigator aimed to recruit a sample of 20-30 lung cancer patients for the
study. This number of subjects matched the number provided within the example of a
grounded theory-guided study in Creswell and colleagues’ (2007) overview of qualitative
research designs. At this number of subjects, the emergent theory should be saturated
with qualitative data such that further data collection from additional lung cancer patients
would provide no more substantive or unique information about the perspective of lung
cancer patients in the LLUMC cancer registry.

Sampling Strategy
After screening the LLUMC cancer registry for patients with lung cancer, the
manager of cancer outcomes and quality at the Loma Linda University Cancer Center
(LLUCC) emailed only the portion of the registry that includes outpatient cases, inpatient
cases, and emergency visits of cancer patients diagnosed with lung cancer on a monthly
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basis. The investigator selected those patients who have not already been included in an
IRB-approved ongoing study of psychosocial adjustment to lung cancer (see Sanders et
al., 2010) and requested contact information (i.e., phone number(s) and mailing address)
for those selected patients through the manager of cancer outcomes and quality. Once the
contact information was obtained, the investigator called the lung cancer patients and
requested their consent to participate in the ongoing study via telephone.
The inclusion criteria of the proposed study included the following: 1) a diagnosis
of lung cancer, 2) completion of the baseline questionnaire of the ongoing study, 3) the
ability to understand written and verbal English, 4) the ability to speak in English, 5) an
indication that the subject would be interested in participating in future research
(determined by the subject’s response to an item in the baseline questionnaire of the
ongoing study), 6) the expressed verbal consent from the subject, and 7) the completion
of the entire interview schedule. Individuals were excluded from the study if they did not
meet all of the inclusion criteria.
It was expected that the sample recruited for the proposed study would closely
resemble the demographics found in the study conducted by Sanders and colleagues
(2010) because both studies indicate that the sample is selected from accessible
populations from hospitals in southern California, one of which is from the same hospital
(LLUMC). If demographic characteristics of the sample did not change significantly
since the study by Sanders and colleagues (2010), then it was expected that the sample of
lung cancer patients in the proposed study were typically be older (M = 68.5 years, SD =
10.1 years), about evenly distributed between sexes, had an education almost at the high
school level (M = 13.5 years, SD = 2.6 years), mostly composed of Caucasian subjects
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(77.4%), had a little over a year’s time lapse since initial diagnosis (M = 54.1 weeks, SD
= 63.6), and would typically be diagnosed at a later stage (stages III & IV: 44.8%; stages
I & II: 24.7%; stage unknown: 30.5%). In the proposed study, demographic
characteristics regarding the subjects’ age, sex, years of education, ethnicity, time since
diagnosis, type of lung cancer, and stage of disease were reported.
It is also important to consider that subjects included in the proposed study were
considered by Rosenthal and Rosnow (2008) to be “second-level volunteers” (i.e., The
sample recruited for the proposed study consisted of a sample from the “volunteers” in
the ongoing study.). Therefore, it was important to compare the demographics of those
who agree to participate in the proposed study to those who were eligible to participate
but choose not to be interviewed for the proposed study. That comparison demonstrated
whether the sample of lung cancer patients in the proposed study represents a biased
sample compared to those who were eligible but did not participate. Specifically, chisquare (for tests involving categorical variables) and t-tests (for tests comparing
continuous variables) comparing demographic information between the those who opted
not to participate in the proposed study (despite being eligible) and those who completed
the interviews informed the investigator whether the study sample was externally valid to
the available population of lung cancer patients.

Study Setting and Materials
The proposed study was conducted in the Behavioral Oncology Laboratory (BOL)
at Loma Linda University. Specifically, all telephone calls to eligible participants,
storage of recorded interviews, transcriptions of interviews, and qualitative analysis of
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the interview data took place in the BOL. The BOL was considered secure because two
separate keys for two different doors were required to access the laboratory.

Interviews
The interviews were recorded via a digital recorder, which were connected
directly to the telephone line. During the administration of the interview, the investigator
referred to an interview protocol (see Appendix) to standardize the interview format.
Recordings captured words from both the investigator as well as the participant. Since
the recorder was outfitted with a built-in USB interface, each recorded interview was
downloaded and saved onto Apple i-Tunes software to be played back for the purpose of
transcribing the interview verbatim. Transcriptions were be typed and saved onto
Microsoft Word documents to facilitate the printing of the multiple copies necessary for a
qualitative analysis (Strauss & Corbin, 1998). All hardcopies of the transcripts were
stored in a file cabinet within the Behavioral Oncology Laboratory (BOL). All
recordings of the interviews were saved on a password-protected hard drive. At the
conclusion of the study, the saved recordings were erased from the hard drive; and no
copies of the interviews were retained (in either paper or digital format).

Interview Protocol
The interview protocol included a script that the investigator used to greet the
participant, inform the participant about the purpose of the interview, and conduct the
recorded interview (see Appendix). The interview protocol contained separate scripts
depending on patient responses to questions regarding participation (e.g., If the patient
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responds with “Yes,” then reply…”) as well as a script for calls made on the day of a
scheduled interview (i.e., If a participant wishes to reschedule the interview, a different
script is provided to the investigator to use for such a call.).
The interview schedule was in a semistructured format; qualitative data was
gathered from participants’ responses to open-ended questions (e.g., “When you think
about it, what types of needs do you usually require help with?”) and fixed questions
(e.g., “On a scale from one to ten, one being little to no interest and ten being extremely
interested, what is your level of interest in the following ways of meeting your needs…”).
A list of recommended probes appeared at the bottom of the interview schedule to query
for more information about a response. The semistructured format was chosen to allow
for variability in individual responses and to facilitate a standard method of administering
the recorded interview. The content of the questions included in the interview schedule
were generated to address the three aims of the proposed study. Specifically, the first
three sections of the interview schedule (see Appendix) addressed the three aims of the
study, and sections 4 and 5 are supplemental to qualitative data from the three previous
sections.

Procedure
A flowchart of the recruitment of participants over the course of the current study
can be viewed in Figure 1. Investigators attempted to recruit lung cancer patients who
have completed the baseline questionnaire of the ongoing study in a two-step process: 1)
An envelope containing a consent sheet and a letter explaining that a researcher will be
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Completed Baseline
Questionnaire of the
Ongoing Study

Unable to Contact
Eligible Participant or
not available

(N = 230)

(n = 193)

Approached for
participation
Unwilling/unable to
participate or could not
be contacted

(n =37)

(n = 16)
Willing to participate:
scheduled an interview
(n = 21)
Began Interview
(n = 13)

Could not be reached
(n = 4)

Lost to followup

Opted out during
interview
(n = 1)

(n = 7)

Complete Interview
(n = 12)

Figure 1. Flowchart of recruitment and attrition in the current study.

calling within the next two weeks will be mailed to the potential participant, and 2) an
investigator will call the potential participant within two weeks.
After sending the letter to the potential participant, an investigator attempted to
contact him/her by telephone. If the lung cancer patient answered the call, then the
investigator determined whether he/she is willing and able to participate in the proposed
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study. However, if the patient did not answer the call, two more attempts were made to
contact the potential subject before his/her name will be dropped from the list of eligible
participants to contact. Also, if a participant wished to opt out of the proposed study,
he/she was not contacted again regarding participation in the proposed study.
If the participant was willing to participate yet needed to reschedule the interview
for a later date, then the investigator asked for another time that will work for
interviewing the patient. The investigator then contacted the participant on the desired
day and time that was mutually agreed upon by both the investigator and the participant.
If the patient was no longer willing or able to participate in the proposed study, then the
investigator no longer contacted him/her.
Before the interview was conducted, participants were reminded that they have
the option to opt out of the interview and end their interview session at any time.
Recordings of any interview sessions in which the patient opted out in the middle of the
interview was immediately erased and not used in the qualitative analysis of the data.
When the interview was conducted, a semistructured interview format was
utilized to provide some standardization of responses directed towards the aims of the
proposed study. However, some flexibility was provided in patient responses by openended questions to explore the perspective of the population, which may have been
missed if more fixed questions were asked.
Just prior to beginning the interview, the investigator was cued by the interview
protocol to begin recording the interview. A digital recorder recorded the two-way
discourse between the investigator and the patient. The recorder was connected directly
to the telephone line to capture the entire interview. After the interview was complete,
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the investigator was cued by the interview protocol to stop the recording of the telephone
conversation between the researcher and the patient.
Utilizing the built-in USB interface of the digital recorder, the investigator
downloaded the audio recording data onto Apple i-Tunes in .mp4 format. Each separate
participant’s recording was saved onto different audio files, using their identification
numbers from the ongoing study (i.e., the same identification number that appears on the
baseline questionnaire they completed in the ongoing study) to indicate which recording
belonged to a given participant. Once the audio recordings were saved onto i-Tunes, the
investigator played them back through headphones and transcribed them onto Microsoft
Word documents. The patients’ identification numbers from the ongoing study was also
used in the names of the saved Word documents. All digital recordings and Word
documents pertaining to the proposed study were saved onto a password-protected hard
drive in the BOL. The transcriptions of the recordings were printed for the purpose of a
qualitative analysis of the interviews. All printed transcriptions were kept within a file
cabinet within the BOL.
Also, demographic information from the baseline questionnaire of the ongoing
study were used in a quantitative analysis. The IBM Statistical Package for the Social
Sciences version 19 (SPSS) was utilized in the quantitative analysis portion of the
proposed study.
At the conclusion of the current study, all digital audio recordings and
transcription files saved onto the password-protected hard drive were erased. Also, all
printed transcriptions of the interviews were destroyed at the current study’s completion.
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Demographic Information
A questionnaire was used to assess sex, age, education level, level of income,
lung cancer type, stage of cancer, time since diagnosis, and smoking status.

Supportive Care Needs Survey (SCNS)
The SCNS is a 31-item measurement of the level of perceived need, which uses a
five-point Likert scale that ranges from 1-5. The range of scores for each individual item
can be split between the 1-2 range as having no need for the item (1 = “not applicable”
and 2 = “satisfied”) and the 3-5 range as having some level of need represented by the
item (3 = “low need,” 4 = “moderate need,” and 5 = “high need”). The overarching
factor (Total Supportive Care Needs [TSCN]) was used. This scale has been shown to be
a reliable instrument when used in samples of cancer patients (Li & Girgis, 2006; Sanders
et al., 2010). The internal consistency of this measure was acceptable in the current
study,  = .79.

Data Analysis
Analysis of the data obtained for the proposed study involved quantitative and
qualitative data: 1) Analysis of quantitative data obtained from the information provided
in the baseline questionnaires of the ongoing study and 2) analysis of qualitative data
from the interviews.
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Quantitative Data Analysis
The purpose of the quantitative analysis portion of the proposed study was to
determine whether selection of participants were biased based on demographic
characteristics and total supportive care needs (TSCN). If the study sample was not
significantly different across demographic characteristics and TSCN when compared to
eligible patients, then it was assumed that the selection of participants was not biased.
However, if significant differences in demographic characteristics were found, then the
results of the qualitative analysis would be interpreted with caution, and it would be
noted that the results from the qualitative analysis might be unique to the sample of
patients who participated in the study.
Demographic characteristics that were included in the analyses are the following
variables: sex (male or female), age, ethnicity (Caucasian or other ethnicity), weeks since
diagnosis, type of cancer (non-small cell, small cell, or not sure), and stage of cancer
(Stages I, II, III, IV, or not sure). Chi-square analyses were used to test for differences
between the patient who completed interviews and those who were eligible and opted out
of the study or could not be contacted on categorical demographic variables (i.e., sex,
ethnicity, type of cancer, and stage of cancer). Continuous demographic variables were
assessed by one-sample t-tests, using the means from the larger sample of lung cancer
patients as the theoretical averages of the population (i.e., age, weeks since diagnosis,
education, and TCSN). The significance level was set at  = .05.
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Qualitative Data Analysis
An outline of the method used to analyze the qualitative data is shown in Figure 2
(p. 45). The analysis of the interview data was guided by a GT design, specifically
utilizing the methodology from Strauss and Corbin’s Basics of Qualitative Research:
Techniques and Procedures for Developing Grounded Theory (1998). Since the current
study addressed three aims, qualitative data gathered from sections 1, 2, and 3 from the
interview schedule (see Appendix) will be analyzed separately to directly address each
separate aim. Responses from section 4 of the interview schedule was considered
supplemental data to section 2 because it may provide additional data regarding lung
cancer patients’ preferences for psychosocial interventions. Any data from section 5 of
the interview (i.e., “Are there any other things that you would like to mention before we
end the interview?”) was only considered supplemental data to answer the three aims of
the proposed study if it was considered relevant and was apparent how the response
related to a given study aim.
First, a qualitative analysis of the interview transcripts began with a line-by-line
analysis of the content of the patient responses to queries from the interview. Categories
(i.e., phenomena) were conceptualized during this sequential analysis and were informed
by the context of the response content around each phenomenon identified as well as by
the context of the patient (e.g., adjusting to the treatment and diagnosis of lung cancer).
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Step 1: Line‐by line analysis
Initial concepts and phenomena were formed

Step 2: Memos written
Range of potential meanings of initial concepts informed the labeling of
phenomena

Step 3: Labeled phenomena were reviewed
Concepts were consolidated into broader or more abstract phenomena

Step 4: Axial coding
Concepts were refined according to commonly expressed dimensions or
properties of that phenomena

Step 5: An experienced qualitative investigator independently reviewed
identified phenomena
Agreement between reviewers determined the final set of categories
Figure 2. Process of qualitative data analysis used in the current study.

Second, the transcripts were reviewed again for the purpose of recording memos
regarding the range of potential meanings within the responses given by the patients. The
investigator specifically commented on the potential meanings of the responses as they
related to the categories identified in the line-by-line analysis of the transcripts. Once
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memos were recorded for each transcript, phenomena were labeled according to themes
that were shared across the patient’s responses.
Third, the accumulated concepts (i.e., phenomena) were reviewed for the purpose
of consolidating phenomena that may be grouped under a broader concept. Grouping of
related concepts occurred in one of two ways: 1) Two or more concepts related to each
other under a single category (e.g., Difficulty driving and difficulty taking public
transportation to a site of treatment can be categorized under a “Transportation Barrier”
phenomenon.), or 2) more abstraction was be necessary to consolidate a high number of
phenomena from the line-by-line analysis and memos (e.g., five or more categories relate
to the abstract concept of “Financial Problems”).
Fourth, axial coding was used to determine whether certain properties or
dimensions of identified phenomena could be grouped to form concepts. For example, if
the content of patient responses that formed a category involved a commonly expressed
dimension, then that property would be included in the label of the phenomenon.
Fifth, the identified concepts (i.e., phenomena) were used to assess inter-rater
reliability. An experienced qualitative investigator independently assessed how the
identified concepts are expressed within the content of the patient responses.
Specifically, the qualitative investigator determined which phrases or sentences indicated
the identified phenomena and whether additional or fewer categories were necessary.
Discrepancies amongst the panel were resolved in a group meeting in which the final
group of identified phenomena was decided.
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CHAPTER THREE
RESULTS

Characteristics of the Study Sample
Out of 230 lung cancer patients who completed the baseline survey of the ongoing
study, 37 (16.09%) were approached for participation in the study. Out of those who
were approached, 3 (8.11%) were deceased, 21 (56.76%) were contacted to schedule an
interview, and 17 (45.95%) scheduled an interview. Of those who scheduled an
interview, 4 (23.53%) could not be reached for the follow-up interview and 1 (5.88%)
opted out of the study. The study sample was composed of 12 lung cancer patients who
completed interviews (see Figure 1).
Table 1 (p. 48) shows the demographic characteristics of the study sample in
comparison to the larger sample that completed at least one baseline survey. Chi-square
and one-sample t-tests demonstrated that the patients that were interviewed did not
significantly differ from the larger sample by sex, age, ethnicity, education, lung cancer
type, stage of cancer, weeks since first diagnosed, and Total Supportive Care Needs. The
study sample (n = 12) was composed mostly of non-Hispanic white (91.7%), female
(58.3%) patients who were typically diagnosed with non-small cell lung cancer (72.7%)
and were uncertain of the progression of their cancer (41.7%). Although participants
were diagnosed less often at stages III (8.3%) and IV (16.7%) compared to the larger
reference group (18.5% and 30.8% diagnosed at stages III and IV, respectively), the
difference was not significant. They were elderly (M = 68.33 years, SD = 7.75 years) but
younger than the median age (71 years) for individuals with lung cancer between
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Table 1
Demographic and Medical Characteristics of the Study and Reference Samples.

Variable
Sex
Male
Female
Ethnicity
White
Other
Type of lung cancer
Non-small cell
Small cell
Other
Don’t know
Stage of cancer
I
II
III
IV
Don’t know

Study Sample
(N = 12)
n(%)

Reference Sample
(N = 230)
n(%)

5(41.7%)
7(58.3%)

94(43.1%)
124(56.9%)

11(91.7%)
1(8.3%)

169(80.1%)
42(19.9%)

8(72.7%)
2(18.2%)
0(0%)
1(9.1%)

107(56.3%)
53(27.9%)
28(14.7%)
2(1.1%)

1(8.3%)
3(25.0%)
1(8.3%)
2(16.7%)
5(41.7%)

31(14.7%)
18(8.5%)
39(18.5%)
65(30.8%)
58(27.5%)

M(SD)
M(SD)
Age
68.33(7.75)
66.95(10.64)
Education
12.67(2.71)
13.48(2.69)
Weeks since first
72.83(108.00)
51.14(72.96)
diagnosed
Total supportive care needs
2.34(0.70)
2.54(0.73)
Note. Discrepancy from the total sample of the Reference Group (N = 230) and totals for
each category due to missing data within those categories.

2004-2008 in the United States (SEER; Howlader et al., 2012). Time since their initial
diagnosis varied greatly from an average of about 18 months (M = 72.83 weeks, SD =
108.00 weeks). Total supportive care needs were between the level of “met need” and
“low need” (M = 2.34, SD = 0.70).
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Findings from the Interviews
From the 12 interviews that were included in the study, emergent themes and
categories were recorded in a codebook. Themes were organized according to each aim
of the current study: 1) determining the most pertinent psychosocial needs of lung cancer
patients, 2) describing perceived barriers in meeting their needs, and 3) evaluating their
level of interest for different methods of delivering psychosocial interventions. Three
themes emerged under the first aim (No Current Psychosocial Need, Physical and
Medical Needs, Current Psychosocial Needs), six themes emerged under the second aim
(Time Constraint, Limited Income, Travel, Lack of Information, Anxiety, Limited
Motivation/Necessity), and different numbers of categories emerged under the five
themes (Internet, Face-to-Face, Support Group, Telephone, Personal Effort) of each
intervention method explored during the interview. All transcripts were double-coded
and checked for inter-rater reliability. Consistency between raters was considered
acceptable, kappa = 0.84.

The Most Pertinent Psychosocial Issues of Lung Cancer Patients
When asked about their needs beyond just medical care, almost half (41.7%) of
the study participants indicated that they either never had any psychosocial need or did
not currently have a need. However, by the end of the interview, every participant
mentioned at least one category pertaining to a specific psychosocial need. Also, specific
physical and medical needs were reported by more than half (66.7%) of the study sample.
Figure 3 (p. 50) shows each category of psychosocial need that was reported.
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Psychosocial Issue

Series1,
Information,
Series1, Fatigue,
58.33% 75.00%
Series1, Anxiety,
50.00%
Series1, Positivity,
41.67%
Series1,
Nutrition/Exercise
Series1,
, 41.67%
Depression,
33.33%
Series1,
Uknown
Etiology, 33.33%
Series1,
Adjustment to
Cancer, Pain,
25.00%
Series1,
25.00%
Series1, Forgetful,
8.33%
Study Sample

Figure 3. Frequency of psychosocial issues reported by the study sample.

Psychosocial issues that were reported by half or more of the interviewed lung cancer
patients were disease and treatment-related information (75.0%), fatigue (58.3%), and
anxiety about future medical exam results or cancer recurrence (50.0%). Almost one-half
(41.7%) of the patients stated that staying positive or seeking the positive in their
situation was important (e.g., “It’s a good thing for people who have cancer to have a
positive perspective.”). The same percentage of participants reported that nutrition or
exercise-related information and support was important to them. One-third of the study
sample (n = 4) reported depressed mood (e.g., “I guess I depress once in a while when I
think about my cancer.”) and difficulty understanding the underlying cause of specific
symptoms (e.g., “I guess right now we’ll be limbo again until we determine what is the
cause of the symptoms I’m having.”). One-quarter of the participants (n = 3) indicated
that pain sensations and adjusting to life with cancer (e.g., “Is this life going to be forever
like this? Okay, I’m living, but it has got a lot of restrictions.”) were problematic. Most
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participants (75%) indicated that they utilized some strategy to address their psychosocial
need, which included spiritual (e.g., “I pray a lot.”), family and friends (e.g., “Well, like I
have mentioned before I have a very nice circle of friends. During those periods of time, I
had a lot of support from them.”), professional support (e.g., “Well, I’m in physical
therapy for pulmonary cardio therapy.”), and personal effort (e.g., “I do most everything
for myself.”) strategies.

Barriers that Hinder Engagement in Psychosocial Interventions
Except for one lung cancer patient, participants perceived at least one barrier that
might hinder meeting their psychosocial needs. Descriptions and examples of the
emergent themes of barriers are displayed in Table 2 (p. 52).
Barriers related to the theme of Time were reported most frequently (n = 6,
50.0%), which involved being busy and having difficulty with scheduling times that
would work for the patient. Almost one-half (41.7%) of the participants stated that
categories related to the theme of Travel (i.e., travel expense, inability to drive, long
distance) were barriers to meeting their psychosocial needs. One-third (n = 4) perceived
that Finance/Income problems and limited Necessity/Motivation served as barriers. Two
participants (16.7%) reported that categories related to the theme of Anxiety (i.e., fear of
cancer recurrence, not wanting to bother others for support) hindered their seeking for
help. Another two patients stated that a barrier was Lacking Information about what a
psychosocial intervention might entail. Barrier themes and their frequency of emergence
in the study sample are displayed in Figure 4 (p. 53).
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Table 2
Emergent Theme Descriptions and Examples of Barriers to Intervention Engagement.
Theme
Time

Description
There are too many demands for one’s
time, and it may be too difficult to
schedule attendance for an intervention.

Travel

The process of arriving at the site where
the intervention takes place might be
problematic due to the long distance
from one’s residence, the cost of travel,
or limitations in ability to drive a
vehicle.

Necessity/motivation The patient perceives that their
likelihood of attending an intervention
is directly related to their level of need
and motivation to engage in an
intervention.

Finance/income
Anxiety

Lacking information

The chance of attending an intervention
is lower due to financial burden or low
income.
A manifestation of worry or anxious
feeling is bothersome and lowers the
likelihood of intervention attendance.
Anxious feelings might be caused by
fear of cancer recurrence or worry that
receipt of assistance will be a bother to
others.

Prior knowledge of an intervention,
such as how it is delivered and what
might be expected of intervention
attendees, affects interest.
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Interview example
“You still got family to take
care of, things to do, errands
to run.”
“I have to adjust my
scheduling to work around
that.”
“I’m not driving because of
this sleepiness and other
problems I am having.”
“With gas prices and things
like that, it’s hard to go
anywhere anymore.”
“I got tired of going there. It’s
too far from me.”
“Sometimes when I got into,
‘oh I think I’m going to do
this,’ then I think about it a
while longer and then I don’t
do it anymore because my
motivation isn’t as strong as it
was 2 weeks before or
whatever.”
“I don’t feel like I need it.”
“When you get sick like this,
your bills go up and your
income goes down.”
“Always in the back of my
mind is just how is it gonna
come back again and get
worse.”
“I really don’t want to put
other people…make them
have to run back and forth for
me because I don’t think that
is fair. I don’t like to bother
people.”
“My enthusiasm would
probably be a lot better or a lot
worse if I knew exactly what it
pertains to.”

Series1, Time,
50.00%

Intervention Barrier

Series1, Travel,
41.67%
Series1,
Necessity/Motivati
on, 33.33%
Series1,
Finance/Income,
33.33%
Series1, Anxiety,
16.67%
Series1, Lacking
Information,
16.67%

Study Sample

Figure 4. Frequency of barriers reported by the study sample.

The Most Desired Methods of Psychosocial Intervention Delivery
Participants were asked to rate their level of interest (using a 1-10 scale) in
receiving psychosocial services through the following modalities: Internet, face-to-face,
support group, telephone, and personal effort (i.e., no external support). After providing
their interest rating, the interviewer asked patients for their rationale, which led to the
emergence of categories under each intervention theme (i.e., mode) to help explain why
individual patients might assign a certain magnitude of interest. Average interest levels
for intervention methods explored in the study are shown in Figure 5 (p. 54).
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Mean Interest Level

Series1, Faceto-face, 6.21

Series1,
Self/Personal,
6.13

Series1,
Telephone, 5.38

Series1,
Series1,
Support Group,
Internet, 4.79
4.77

Intervention Method

Figure 5. Average interest ratings for psychosocial delivery methods.

The highest mean levels of interest were in face-to-face (M = 6.21, SD = 3.50)
and personal effort (M = 6.13, SD = 2.30) methods of intervention. Eighty-three percent
(n = 10) and 75% (n = 9) of the participants rated their interest as a five or higher in
personal effort and face-to-face methods of intervention, respectively. Participants’ mean
interest ratings for Internet (M = 4.79, SD = 2.74), support group (M = 4.77, SD = 3.39),
and telephone (M = 5.38, SD = 3.15) methods of intervention were about the middle of
the 1-10 scale. Two-thirds (n = 8) of the participants rated the Internet and telephone at
an interest level of five or higher. It should be noted that one participant could not rate
his level of interest in a support group method of intervention.

Internet
Four categories emerged from the rationales provided for interest ratings
regarding Internet-based psychosocial interventions: reliability, source of information,
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current usage, and limited use or no interest. One-quarter of the participants (n = 3)
explained that the reliability of information from the Internet influenced their ratings,
typically inciting caution in those participants (e.g., “Sometimes I don’t know how
reliable the source is.”). Usually when explaining why the participant rated their interest
in the Internet as a five or higher, participants (n = 4, 33.3%) perceived the Internet as a
source of information (e.g., “Well, the Internet helps a lot. It gives you information.”).
One participant (8.3%) indicated that currently using the Internet influenced the interest
rating. However, five participants (41.7%) indicated that not using the Internet or having
no interest in using the Internet explained their low interest ratings. Interviews from two
of the participants provided no categories under the Internet theme.

Face-to-Face
Four categories emerged from the rationales provided for interest ratings given
regarding face-to-face interventions: tailored and immediate information, nonverbal
communication, trusted expert and professional support, and no interest. Two
participants (16.7%) indicated that having information that was specific (i.e., tailored to
their case) and immediate from another individual was important to them (e.g., “The
reasoning behind that is as you are seeing or talking about things, questions arise while
you are talking. You want an answer and right then.”). Three participants (25.0%)
reported that viewing an individual’s nonverbal communication was important to them
(e.g., “You can read a lot in the expression of a person.”) and also influenced one of their
ratings to be higher than telephone-based interventions (e.g., “It was easier for me to read
somebody by having one-on-one contact.”). One-half (n = 6) of the study sample
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indicated that receiving face-to-face support from an individual recognized as a trusted
professional or expert was important to them (e.g., “I think I want to be one-on-one with
a doctor.”). Three participants (25.0%) reported having limited interest in receiving faceto-face support. Interviews from three participants contained no categories under the
theme of face-to-face interventions.

Support Group
When participants were queried for their rationales for their interest ratings in a
support group format for an intervention, seven categories emerged. The categories
included timing of joining a group (i.e., does it coincide with current need or future
need), having previous experience in a support group, being in a group of individuals that
share common experiences (e.g., specific cancer type), hearing positive and hopeful
aspects of group members’ experiences, disliking hearing about stories from others in the
group, desiring an expert panel (i.e., professionals or experts compose the group members
to inform the patient), and no interest. Out of those categories, participants (n = 5,
41.7%) most frequently stated that having a group composed of members with similar
experiences (e.g., having lung cancer) was important to them (e.g., “People with the same
diagnosis can relate more to each other.”). It was also stated that finding groups that
shared a lung cancer diagnosis was difficult to find (e.g., “I was trying to find a support
group, but all you can find is breast cancer.”). Three participants (25.0%) reported that
their interest in a support group depended upon whether they perceived that they needed
it at that time, which might increase or decrease depending on the severity of their
physical and emotional distress (e.g., “Maybe if it occurred again…if I had another
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recurrence. That might change my mind. I don’t know.”). One-quarter (n = 3) of the
study sample also indicated that listening to positive and hopeful stories was an important
component of a support group (e.g., “…hearing their stories…their positive stories.”).
Two participants (16.7%) stated that previous experience with a support group influenced
their interest level. Two participants also stated that their low interest level was
influenced the desire to not talk about experiences with cancer among other people (e.g.,
“I always shied away from them. That may be because I don’t like speaking of things
like that with others.”). One participant (8.3%) stated that interest would be high
dependent on whether the group was composed of a group of professionals who would
inform the individual on what to do given the individual’s case (e.g., “If it was a group of
doctors talking about it saying, ‘This is what we can do,’ that would be different.”).
However, four participants indicated that they would not be interest in a support group
format. Interviews from two participants contained no categories under the theme of
support group interest.

Telephone
Four categories emerged from rationales provided for relative interest levels in a
telephone-based psychosocial intervention. Categories included convenience of
telephone use, previous experience in using a telephone-based support service, receipt of
reliable support (e.g., from a professional), and no interest. Three participants (25.0%)
reported that previous use of a telephone-based service influenced their interest rating.
Two participants (16.7%) stated that their high interest ratings were attributable to the
convenience of a telephone-based service (e.g., “I could call a 24-hour nurse line.”). Two
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other participants indicated that having reliable support and information (e.g., from an
expert) would influence their interest levels (e.g., “I could rely on the information that
they give me.”). Two participants indicated that they were not interested in telephonebased service. Interviews from four participants contained no text in the four categories
to explain rationales for telephone use.

Personal Effort
Four categories emerged from analyzing the rationales of interest levels regarding
personal effort in meeting needs: perceiving themselves as information gatherers,
desiring some guidance in seeking help or information, feeling little motivation without
external help, and using the Internet. Five participants (41.7%) stated that they saw
themselves as information gatherers and recalled events in which they gathered
informational resources relevant to them (e.g., “I try to get information from the people I
know…from all the doctors.”). Four participants (33.3%) specified that they utilized the
Internet as a tool to meet their information-seeking needs (e.g., “I use the computer a lot
for my health.”). One participant (8.3%) explained that his low rating was due to needing
guidance in meeting personal needs (e.g., “I would like to know where to find reliable
research.”). Another participant indicated that his low interest was due to limited
motivation without the external support. Interviews from two participants contained no
categories to explain interest levels in implementing personal efforts to meet needs.
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CHAPTER FOUR
DISCUSSION

Lung Cancer Patients’ Most Pertinent Psychosocial Needs
Although about half (41.7%) of the lung cancer patients in this study initially
reported no current psychosocial needs, all patients indicated some psychosocial need
that was pertinent to them. These findings from this study suggest that the most pertinent
psychosocial needs for lung cancer patients are more information regarding lung cancer
and its treatment, fatigue, and anxiety about future medical results or about negative
effects from cancer (each reported by over half of the participants). This matches
moderately well with the findings from Sanders et al. (2010), whose quantitative findings
suggested that lack of energy or tiredness (i.e., fatigue; 75%), uncertainty about the future
(64%), and work around the home (64%) were the most endorsed unmet supportive care
needs. In the same study, although information about diagnosis and treatment was not
the most reported unmet need, more lung cancer patients indicated interest in services
offered free of charge that were geared towards meeting that need (i.e., information;
61%) compared to any other type of service. Also, Devitt et al. (2010) found that the
most desired content for a support group was information related to lung cancer and its
treatment (96-78% for specific categories of information). The rates of categories of
reported psychosocial needs appeared to match well with Sanders et al. (2010). For
example, Sanders and colleagues reported a slightly lower (66%) rate of unmet need in
the health system and informational domain, a similar rate of lung cancer patients who
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met the CES-D cutoff for depression (37.4%), and a similar rate of anxiety (about 49%)
when compared to the lung cancer patients interviewed in this study.

Barriers that Hinder Lung Cancer Patients’ Engagement in
Psychosocial Interventions
The barriers reported most frequently by lung cancer patients in this study were
time-related and travel-related issues, followed by barriers of limited motivation or
necessity as well as limited finances. The travel barrier has been reported in the findings
of Devitt et al. (2010). Besides not wanting to participate in a support group (most often
reported), Devitt and colleagues found that the barriers most often expressed by lung
cancer patients were difficulty with transportation and parking (38%), not wanting to
travel (37%), and not wanting to talk about lung cancer (37%).

Lung Cancer Patients’ Interest in Specific Modes of Intervention
Delivery
The findings from this study indicated that lung cancer patients were most
interested in interventions delivered via face-to-face methods. They also showed a
similar level of interest in meeting their psychosocial needs for information via personal
effort (i.e., limited external support). However, more lung cancer patients stated that
their interest level was a five or greater for meeting their needs through personal effort
(83.3%) compared to their interest ratings given for a face-to-face format (75%).
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Internet-based Format
Internet-based psychosocial interventions directed toward lung cancer patients
may be more likely to be utilized if it is clear that it is from a reliable source (e.g., cite
journal articles for informational interventions). Patients may also show more interest if
Internet-based interventions advertise the breadth and depth of information that is
provided by the website.

Telephone-based Format
Psychosocial interventions delivered through the telephone should focus on
emphasizing its convenience to lung cancer patients, especially when time-related and
travel-related barriers are apparent. Also, the credibility of the individual (e.g., the
credentials) speaking to the lung cancer patient should be made clear.

Support Group Format
According to the findings of Devitt et al. (2010) and this study, it is important for
lung cancer patients to be in a support group with others who are also diagnosed with
lung cancer. Given that some participants in the this study indicated that the timing (i.e.,
whether I believe that I am currently in need of a support group now) of when the support
group is offered could affect their interest, it may be useful for lung cancer patients to be
clearly informed of what needs a given support group can fill.
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Limitations
This study had several limitations. Since the interviews were carried out in a
cross-sectional design, lung cancer patients’ experiences could be captured only at one
point in time and may not reflect what their perspectives were before and after the
interviews. Also, the study suffered from a low sample size (n = 12), which is lower than
the sample size recommended (n = 20) by Creswell et al. (2007). Further, the study
sample is less often diagnosed at later stages of cancer progression (i.e., stage III and
stage IV) and less ethnically diverse when compared to national estimates of regional
(22%) and distant (56%) spread of cancer from the lungs and bronchus and estimates of
the ethnic distribution of the age-adjusted lung cancer incidence (60.55 for white and
69.16 for black ethnic groups per 100,000 individuals in the United States in 2008;
SEER). The low sample size and lack of similarity to the national population of lung
cancer patients possibly bias the results from this study and limits the study’s external
validity.

Implications for Psychosocial Intervention Development for Lung
Cancer Patients
Psychosocial interventions can address lung cancer patients’ most pertinent needs
if information regarding lung cancer and its treatments, fatigue-related support, and
services that address patients’ anxiety about future medical exam results or cancer
recurrence are provided in a face-to-face format or via resources accessible by the
patients (e.g., the Internet). Lung cancer patients should be offered interventions at times
and locations that facilitate their engagement. Also, the intervention should be efficiently
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delivered such that as little of the patient’s time is taken. If available, they should be
made aware of transportation services that can deliver them to the site of the intervention
and financial reimbursements for which they qualify to address travel-related and
income-related barriers. Given that a lack of information about psychosocial
interventions was a barrier for several patients in this study, it is important to be clear
about what is offered and what involvement entails for a patient in any intervention.
Considering the diversity of psychosocial needs presented by lung cancer patients in this
study and across previous studies (e.g., Sanders et al., 2010 and Li & Girgis, 2006), any
psychosocial intervention should begin with a subjective needs assessment of the target
population (Green & Kreuter, 2000). After determining their available resources,
psychosocial intervention developers may then find how their capabilities can meet the
needs of the target population.

Implications for Future Research
Future investigations regarding psychosocial interventions addressing lung cancer
patients’ psychosocial needs, barriers to engage in psychosocial interventions, and
preferred intervention channels, should be conducted with ethnically diverse samples that
are stratified according to the national distribution of ethnic groups and cancer staging for
lung cancer. Also, a longitudinal replication of this study with a larger sample of lung
cancer patients (n  20; Creswell et al., 2007) would result in good external validity and
facilitate the generalizability of findings to the theoretical population of lung cancer
patients. Given that lung cancer patients have reported that their experience of stigma,
shame, and blame affected their motivation to go to doctor’s appointments (Chapple et
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al., 2004), it may also be informative for future research to specifically explore whether
lung cancer patients’ experience of stigma, self-blame, and shame might affect their
interest or motivation to attend a psychosocial intervention. Although the results from
this study found no barriers related to stigma, shame, or self-blame, it may be due to the
low sample size (biased results) and the format of the interview (i.e., not specifically
asking about self-blame, shame, or stigma). Finally, it may be informative for future
investigations to explore how lung cancer patients perceive barriers to engage in
psychosocial interventions according to the mode of delivery. For example, patients may
perceive a different set of barriers if asked about engagement in a face-to-face
intervention versus an Internet-based intervention.
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APPENDIX

Telephone Script
Hello, this is Kevin Criswell from Loma Linda University. May I speak with
(patient’s name)? Hello (patient’s name). I am calling on behalf of Dr. Jason Owen. We
received your completed questionnaire and I would like to thank you for taking the time
to complete and return it. After reviewing your responses, I noticed that you might be
interested in participating in future research. Did you receive the letter I sent you?
(If patient responds “Yes,” then proceed with the telephone script.)
(If patient responds “No,” then explain that a letter was sent containing a consent
sheet as well as a letter, notifying that he/she will receive a call from a researcher within
the next two weeks. Then proceed with the telephone script.)
I am making this call to ask you to take part in a telephone interview, which may
take about 20 minutes. It will involve questions about nonmedical needs you have, how
you would like those needs to be met, and any difficulties you find in obtaining those
needs. The interview will be recorded and transcribed for use in our study. To thank you
for your time, you will be reimbursed with a $20 gift card to Target. At the conclusion of
the study, the recording and its transcription will be destroyed to protect your
confidentiality. Would you be willing to take part in this interview?
(If patient responds “No,” then reply, “Thank you for your time. Goodbye.”)
(If patient responds “Yes,” then reply with the following script.)
Thank you. Is it okay if we begin the interview now or would you like to
schedule a later time for the interview?
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(If patient responds by saying that he/she would like to begin the interview now,
then reply with the following script.)
We will start in just a moment. Please keep in mind that you may choose to end
the interview at any time. (Skip to the Interview Schedule.)
(If patient responds by saying that he/she would like schedule the interview at
another time, then reply with the following script.)
When would you like to schedule our interview? (Record the time that the
participant and an investigator can mutually agree on.) Okay, I will be calling you back
on [recite the agreed time to conduct the interview]. Thank you for your time. Goodbye.

Scheduled Interview Call
Hello, this is Kevin Criswell from Loma Linda University. May I speak with
(patient’s name)? Hello (patient’s name). I called you a while ago to ask if you could
take part in an interview about any nonmedical needs you have, how you would like
those needs to be met, and any difficulties you find in obtaining those needs. When we
talked, you had mentioned that this time would work for taking part in this interview.
Are you ready to begin the interview?
(If patient responds by saying that he/she would like to begin the interview now,
then reply with the following script.)
We will start in just a moment. Please keep in mind that you may choose to end
the interview at any time. (Skip to the Interview Schedule.)
(If patient responds by saying that he/she would like schedule the interview at
another time, then reply with the following script.)
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When would you like to schedule our interview? (Record the time that the
participant and an investigator can mutually agree on.) Okay, I will be calling you back
on [recite the agreed time to conduct the interview]. Thank you for your time. Goodbye.
(If patient responds by saying that he/she does not want to participate, then reply,
“Okay. Thank you for your time. Goodbye.”)

Interview Schedule
(Begin recording the interview.)
1.

Please think about how you are currently living with your cancer every day.
When you think about it, what types of needs do you usually require help with?

(Probe: Of those needs, which would you consider to be the most important to you?
Why? On a scale from one to ten, one being little to no interest and ten being extremely
interested, how interested are you in receiving support for your most important need?
Why?)
2.

On a scale from one to ten, one being little to no interest and ten being extremely

interested, what is your level of interest in the following ways of meeting your needs:


Internet ___ Why is it a (the number the patient indicated for Internet)?



Face-to-face ___ Why is it a (the number the patient indicated for Face-to-face)?



A group of others who have also been diagnosed with lung cancer ___ ___ Why is it
a (the number the patient indicated for a lung cancer support group)?



Telephone ___ Why is it a (the number the patient indicated for Telephone)?



On your own (e.g., reading materials, website, etc.) ___ Why is it a (the number the
patient indicated for personal research)?
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3. Now, I am going to ask you about what you think might get in the way of seeking help
for any of your needs. Some of these roadblocks for seeking help can include personal,
social, physical, financial, or other areas of life. Please tell me specifically why you
would find it difficult to seek help to get your needs met.
(Probe: Of those difficulties, which do you consider most troublesome? Why?)
4. At the place where you receive or have received treatment for your cancer, have you
been given information about any support services that you are eligible to receive?
(Probe if any services are recalled: Can you recall what services are offered? Of those
services that you recall, which ones interest you the most?)
5.

Are there any other things that you would like to mention before we end the

interview?
(Stop recording the interview.)
Thank you for your time. Your responses will be kept confidential and will help
us to develop more effective nonmedical services for lung cancer patients. Also, you will
receive your $20 reimbursement by mail. Have a good day.
(Hang up the phone.)
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